IMRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Immuneering Corp

Watchlist Manager

Watchlist

Price: 4.78 USD -7.36% Market Closed

Market Cap: $309.3m

I	Immuneering Corp NASDAQ:IMRX	US
	Claros Mortgage Trust Inc F:5WO	US
W	Walgreens Boots Alliance Inc XMUN:W8A	US
T	Teleflex Inc F:TBH	US
	Cicor Technologies Ltd SIX:CICN	CH
J	Juniper Networks Inc XHAM:JNP	US
T	Telefonaktiebolaget LM Ericsson F:ERCG	SE
G	Graphic Packaging Holding Co F:4W8	US
	Pick N Pay Stores Ltd F:PIK	ZA
M	Myriad Genetics Inc DUS:MYD	US
	TuSimple Holdings Inc OTC:TSPH	US

Profitability Summary

Immuneering Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

50%

Low Operating Margin

Negative 3Y Average Operating Margin

-138.400%

Low Net Margin

Negative 3Y Average Net Margin

-129.700%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-120.275%

Negative ROE

-43%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-408%

ROIC is Increasing

-427% > -164%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.